Evidence map›Paper›PMID 34406362›Full record

ArticleThe Journal of experimental medicine2021

Hepatic FGF21 preserves thermoregulation and cardiovascular function during bacterial inflammation.

Sarah C Huen, Andrew Wang, Kyle Feola, Reina Desrouleaux, Harding H Luan, Richard Hogg, Cuiling Zhang, Qing-Jun Zhang, Zhi-Ping Liu, Ruslan Medzhitov

Open access · greenAbstract read
In one paragraph

Article in The Journal of experimental medicine, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 23 papers.

0numbers the graph read from it
0cells of the map it votes in
23citing papers in PubMed
2.8field-weighted citation impact, top 8% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

23 citing papers in PubMed, 45 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Review
  5. Article
  6. Article
  7. FGF21 acting on the noradrenergic nervous system protects against influenza virus infection.Proceedings of the National Academy of Sciences of the United States of America · 2025
    Article
  8. Article
  9. Article
  10. Article
  11. Review
  12. Article
  13. Review
  14. Review
  15. Article
  16. Review
  17. Review
  18. Review
  19. Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 3 institutions in 1 country.

Sarah C HuenDepartment of Internal Medicine (Nephrology) and Pharmacology, University of Texas Southwestern Medical Center, Dallas, TX.ORCID 0000-0001-6420-2400
Andrew WangDepartment of Internal Medicine (Rheumatology), Yale University School of Medicine, New Haven, CT.ORCID 0000-0002-6951-8081
Kyle FeolaDepartment of Internal Medicine (Nephrology) and Pharmacology, University of Texas Southwestern Medical Center, Dallas, TX.ORCID 0000-0002-1190-9696
Reina DesrouleauxDepartment of Internal Medicine (Rheumatology), Yale University School of Medicine, New Haven, CT.ORCID 0000-0002-3570-0125
Harding H LuanDepartment of Immunobiology, Yale University School of Medicine, New Haven, CT.ORCID 0000-0003-2044-2159
Richard HoggDepartment of Internal Medicine (Nephrology) and Pharmacology, University of Texas Southwestern Medical Center, Dallas, TX.
Cuiling ZhangDepartment of Internal Medicine (Rheumatology), Yale University School of Medicine, New Haven, CT.ORCID 0000-0002-6236-7356
Qing-Jun ZhangDepartment of Internal Medicine (Cardiology) and Molecular Biology, University of Texas Southwestern Medical Center, Dallas, TX.ORCID 0000-0002-0749-642X
Zhi-Ping LiuDepartment of Internal Medicine (Cardiology) and Molecular Biology, University of Texas Southwestern Medical Center, Dallas, TX.ORCID 0000-0003-1341-3878
Ruslan MedzhitovDepartment of Immunobiology, Yale University School of Medicine, New Haven, CT.ORCID 0000-0002-7021-2012
The University of Texas Southwestern Medical Center · USYale University · USHoward Hughes Medical Institute · US

Funding

Yale Clinical and Translational Science Award (U Component)UL1TR001863 · NCATS · YALE UNIVERSITY · PI John H. Krystal, LUCILA OHNO-MACHADO · 2016 to 2026
$102.9M
Yale Liver CenterP30DK034989 · NIDDK · YALE UNIVERSITY · PI MICHAEL H NATHANSON, Mario Strazzabosco · 1986 to 2026
$31.1M
UT Southwestern O'Brien Kidney Research Core CenterP30DK079328 · NIDDK · UT SOUTHWESTERN MEDICAL CENTER · PI MOE, ORSON W · 2007 to 2021
$16.9M
Renal Physiology and Phenotyping CoreP30DK079310 · NIDDK · YALE UNIVERSITY · PI SOMLO, STEFAN · 2008 to 2022
$16.8M
TRAINING PROGRAM IN INVESTIGATIVE RHEUMATOLOGYT32AR007107 · NIAMS · YALE UNIVERSITY · PI RICHARD J BUCALA · 1986 to 2026
$7.5M
Cell Biology of TLR Signal TransductionR37AI046688 · NIAID · YALE UNIVERSITY · PI MEDZHITOV, RUSLAN · 2006 to 2015
$3.8M
Harnessing Fasting Metabolism to Improve Survival in Bacterial SepsisR35GM137984 · NIGMS · UT SOUTHWESTERN MEDICAL CENTER · PI HUEN, SARAH · 2020 to 2024
$2.2M
Role of GDF15 in the Regulation of Host Tolerance to InflammationR01AI144152 · NIAID · YALE UNIVERSITY · PI MEDZHITOV, RUSLAN · 2019 to 2023
$2.1M
Role of basophils in initiating Th2 immune responsesR01AI089771 · NIAID · YALE UNIVERSITY · PI MEDZHITOV, RUSLAN · 2010 to 2014
$2.0M
Memory of DNA DamageR01CA157461 · NCI · YALE UNIVERSITY · PI MEDZHITOV, RUSLAN · 2011 to 2015
$1.7M
TOLL RECEPTORS AND CONTROL OF MAMMALIAN IMMUNITYR01AI046688 · NIAID · YALE UNIVERSITY · PI MEDZHITOV, RUSLAN · 2001 to 2005
$1.5M
The Role of Kidney FGF21 in Surviving SepsisK08DK110424 · NIDDK · YALE UNIVERSITY · PI HUEN, SARAH · 2016 to 2020
$833k
Howard Hughes Medical InstituteNCATS NIH HHS UL1 TR001863NCI NIH HHS R01 CA157461NIAID NIH HHS K08 AI128745NIAID NIH HHS R01 AI046688NIAID NIH HHS R01 AI089771NIAID NIH HHS R01 AI144152NIAID NIH HHS R37 AI046688NIAMS NIH HHS T32 AR007107NIDDK NIH HHS K08 DK110424NIDDK NIH HHS P30 DK034989NIDDK NIH HHS P30 DK079310NIDDK NIH HHS P30 DK079328NIGMS NIH HHS R35 GM137984NIH HHS AI046688NIH HHS K08DK110424NIH HHS P30-DK079310NIH HHS P30-DK079328NIH HHS T32 AR07107-39
6 · The paper itself

Abstract

Sickness behaviors, including anorexia, are evolutionarily conserved responses to acute infections. Inflammation-induced anorexia causes dramatic metabolic changes, of which components critical to survival are unique depending on the type of inflammation. Glucose supplementation during the anorectic period induced by bacterial inflammation suppresses adaptive fasting metabolic pathways, including fibroblast growth factor 21 (FGF21), and decreases survival. Consistent with this observation, FGF21-deficient mice are more susceptible to mortality from endotoxemia and polybacterial peritonitis. Here, we report that increased circulating FGF21 during bacterial inflammation is hepatic derived and required for survival through the maintenance of thermogenesis, energy expenditure, and cardiac function. FGF21 signaling downstream of its obligate coreceptor, β-Klotho (KLB), is required in bacterial sepsis. However, FGF21 modulates thermogenesis and chronotropy independent of the adipose, forebrain, and hypothalamus, which are operative in cold adaptation, suggesting that in bacterial inflammation, either FGF21 signals through a novel, undescribed target tissue or concurrent signaling of multiple KLB-expressing tissues is required.

Indexed as

AnimalsBacterial InfectionsBody Temperature RegulationEndotoxemiaFibroblast Growth FactorsHeart RateInflammationKlotho ProteinsLipopolysaccharidesLiverMiceMice, Inbred C57BLMice, Mutant Strainsfibroblast growth factor 21Fibroblast Growth FactorsKlb protein, mouseKlotho ProteinsLipopolysaccharides

Identifiers

PMID34406362
PMCPMC8374861
OpenAlexW3195780822

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-SA
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.